Table II.
Clinical characteristics | Luminal A, n | Luminal B, n | HER-2 positive, n | Triple-negative, n |
---|---|---|---|---|
No complications | 36 | 32 | 2 | 4 |
Recurrence | 1 | 2 | 0 | 0 |
Metastasis | ||||
Cutaneous | 2 | 0 | 1 | 0 |
Lung | 3 | 5 | 7 | 12 |
Liver | 0 | 2 | 0 | 1 |
TNM | ||||
I | 15 | 20 | 1 | 3 |
II | 10 | 10 | 2 | 4 |
III | 8 | 2 | 4 | 4 |
IV | 5 | 6 | 1 | 1 |
V | 3 | 1 | 0 | 4 |
Uninformed | 1 | 2 | 2 | 1 |
TNM, Tumor-Node-Metastasis; HER-2, human epidermal growth factor receptor 2.